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BONE MARROW EXAMINATION FINDINGS AT AGA KHAN UNIVERSITY
HOSPITAL, NAIROBI
N.A. OKINDA and M. S. RIYAT
ABSTRACT
Objective: To establish the bone marrow examination ﬁndings and determine the
indication for bone marrow examination.
Design: A retrospective audit.
Setting: Aga Khan University Hospital, Nairobi.
Subjects: All bone marrow aspirates done at Aga Khan University for the period
comprising February 2003 to February 2006 were retrieved and analysed.
Results: A total of 356 patient’s case histories including bone marrow examination
results were analysed. Ages of the patients ranged from 18 months to 91 years. Males
were 180 (50.6%) and females were 176 (49.4%). Nutritional anaemia as a group was
the most common haematological disorder found on bone marrow examination in our
patients with megaloblastic anaemia predominating. Acute myeloid leukaemia was
the most common malignant haematological disorder. The most common indication
for bone marrow examination was anaemia followed by diagnostic work up of fever
of unknown origin.
Conclusion: Nutritional anaemia predominated as the commonest benign haematological
ﬁnding on bone marrow examination while acute myeloid leukaemia was the most
frequent haematological malignancy. Most bone marrow examinations were performed
on patients with anaemia.
INTRODUCTION
Examination of the bone marrow is one of the
most valuable diagnostic tests used to evaluate
haematological disorders. Bone marrow aspiration
and biopsy is also used to stage lymphoproliferative
disorders and for prognostic purposes in chronic
lymphoproliferative disorders such as chronic
lymphocytic leukaemia.
Bone marrow aspiration and biopsy is also
useful in the diagnostic workup of fever of unknown
origin. It may reveal infections, such as tuberculosis,
mycobacterium avium-intracellulare infections,
histoplasmosis, leishmaniasis, and other disseminated
fungal infections. It may be useful in establishing the
diagnosis of storage diseases and diagnosing metastatic
non-haemopoietic malignancies that have spread to the
bone marrow when all other imaging and diagnostic
modalities have failed or when a leucoerythroblastic
peripheral blood picture is present (1).
It is usually not indicated in haemolytic anaemia
and is contraindicated in haemophilia and related
congenital haemorrhagic disorders. Deviations from
the normal may be qualitative with abnormal cellular

morphology or quantitative with aplasia, hypoplasia
or hyperplasia (2). Injury to the great vessels is a
serious albeit rare complication of bone marrow
sternal puncture.
The objective of this study was to establish the bone
marrow examination ﬁndings and indications for
bone marrow examination at Aga Khan University
Hospital, Nairobi.
MATERIALS AND METHODS
This was a retrospective audit. All patients who
underwent bone marrow aspiration during the period
February, 2003 to February, 2006 were included in
this study. Every patient’s history was examined
in detail and ﬁndings were recorded on a standard
proforma including demographic data, symptoms
and signs and all the relevant investigations. Bone
marrow aspiration results were also recorded. Data
was analysed to know the relative frequencies of
different haematological disorders in our patients
and also establish the indications for bone marrow
examination.
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RESULTS
A total of 356 patient’s case histories including bone
marrow examination results were analysed. Ages of the
patients ranged between 18 months to 91 years. Males
were 180 (50.6%) and females were 176 (49.4%).
The indication for the bone marrow examination
were anaemia (26.9%), bone marrow cultures
(17.5%), pancytopenia (17.1%), confirmation of
acute leukaemia or lymphoproliferative disorders
(10.9%), leukoerythroblastic picture (7.5%), exclusion
of multiple myeloma (8.4%), staging of lymphomas
(6.5%), mono cytopenias (5%) (Table 1).

Indication

Acute myeloid leukaemia accounted for (8.1%)
and was found to be the most common malignant
disorder, followed by low grade lymphoproliferative
disorders - chronic lymphocytic leukaemia (6.7%),
multiple myeloma (5.6%), acute lymphoblastic
leukaemia (5.6%), myeloproliferative disorders and
myelodysplastic syndromes (2%), bone marrow
metastasis (2.2%). Other miscellaneous findings
included normal marrow (20.8%), reactive marrow
(14.3%) and inadequacy of material for proper
evaluation (2.8%) (Table 3).

Table 1
Indications for bone marrow examination

Anaemia
Pyrexia of unknown origin
Pancytopenia
Conﬁrmed leukaemia (acute, chronic)
Leucoerythroblastic picture
Staging of lymphomas
Mono cytopenias
Indication for bone marrow examination not stated
Total
Nutritional anaemia contributed 14.9% amongst
the non-malignant haematological disorders. Out of
nutritional anaemia, megaloblastic anaemia was the
most common i.e. (8.1%) followed by iron deﬁciency
anaemia (6.5%) and mixed deﬁciencies (0.3%).
Other non-malignant haematological disorders
were aplastic anaemia (1.3%), pure red cell aplasia
(0.6%), anaemia of chronic disease (0.6%) idiopathic
thrombocytopaenic purpura (ITP) (4.2%), infections
(fungal, tuberculosis, typhoid fever, malaria) (3.7%)
including HIV dyspoiesis (7.3%) (Table 2).
Table 2
Spectrum of non-malignant haematological conditions
Disease
Infections including HIV dyspoiesis
Megaloblastic anaemia
Iron deﬁciency anaemia
ITP
Aplastic anaemia
Suppression of bone marrow
by cytotoxics
Haemolytic anaemia
Anaemia of chronic disease
Pure red cell aplasia
Mixed deﬁciency
Total

Cases
No. (%)
39
11
29
8.1
23
6.5
15
4.7
5
1.3
4
4
2
2
1

1.2
1.2
0.6
0.6
0.3

124

35

5

Cases
No. (%)
96
26.9
62
17.5
61
17.1
36
10.9
27
7.5
21
6.1
18
5
35
9
356

Table 3
Spectrum of malignant haematological conditions
Disease

Cases
No.

(%)

Acute myeloid leukaemia

29

8.6

Lymphoproliferative disorders

24

6.7

Multiple myeloma

20

5.6

9

2

9

2

Myeloproliferative disorders/
myelodysplastic syndrome
Metastatic tumours to the
bone marrow
Acute lymphoblastic leukaemia

6

1.7

Total

97

26.6

Haematinic deficiency was most common
in young adults (19-40 years) (Table 4) so was
aplastic anaemia and ITP; the mentioned disorders
were also commoner in females. Haematological
malignancies had a varied distribution with the
myeloid leukaemia and lymphoproliferative
disorders being commoner in young adults and
myeloproliferative/myelodysplastic disorders
occurring more in the older age group i.e. >40 years
with a more preponderance for males (Table 5).
Acute lymphoblastic leukaemia was commoner in
the younger age group less the 18 years with an
equal sex distribution.
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Table 4
Age distribution of bone marrow aspirate ﬁndings
Bone marrow ﬁnding

1-18 years
% cases
10
21
17
67
0
0
0
0
50
100
11
7
5

Infections including HIV dyspoiesis
Megaloblastic anaemia
Iron deﬁciency anaemia
ITP
Aplastic anaemia
Bone marrow suppression by drugs
Haemolytic anaemia
Anaemia of chronic diseases
Pure red cell aplasia
Mixed deﬁciency
Acute myeloid leukaemia
Lymphoproliferative disorders
Multiple myeloma
Myeloproliferative
12
disorders/myelodysplastic syndrome
Metastatic tumour to the bone marrow
0
Acute lymphoblastic leukaemia
50
Normal marrow
15
Reactive marrow
7
Inadequate material for evaluation
50
ITP = Idiopathic thrombocytopaenic purpura

19-40 years
% cases
67
52
57
33
100
0
50
100
50
0
50
50
18

>40 years
% cases
23
27
26
15
0
100
50
0
0
0
39
43
77

Total cases

41
67
33
43
46
20

47
33
17
42
47
30

9
9
6
74
51
10

39
29
23
5
4
4
2
2
1
29
24
20

Table 5
Sex distribution of bone marrow aspirate ﬁndings
Bone marrow ﬁnding

Female
% cases
42
Infections including HIV dyspoiesis
Megaloblastic anaemia
66
Iron deﬁciency anaemia
56
ITP
66
Aplastic anaemia
50
Bone marrow suppression by drugs
60
Haemolytic anaemia
75
Anaemia of chronic diseases
0
Pure red cell aplasia
50
Mixed deﬁciency
100
Acute myeloid leukaemia
42
Lymphoproliferative disorders
50
Multiple myeloma
59
Myeloproliferative disorders/myelodysplastic syndrome 47
33
Metastatic tumour to the bone marrow
Acute lymphoblastic leukaemia
50
Normal marrow
42
Reactive marrow
47
Inadequate material for evaluation
50
ITP = Idiopathic thrombocytopenic purpura

Male
% cases
58
34
44
34
50
40
25
100
50
0
58
50
41
53
67
50
58
53
50

Total cases
39
29
23
15
5
4
4
2
2
1
29
24
20
9
9
6
74
51
10
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DISCUSSION
The spectrum of haematological disorders in patients
is very wide. Bone marrow examination is a useful
test in reaching the ﬁnal diagnosis. It is one of the
most common and relatively safe procedures done
on patients in medical practice although injury to
the great vessels may be a rare complication of bone
marrow sternal puncture. Rarely have infection,
excessive bleeding or embolism been reported after
bone marrow biopsy (3).
This study shows that amongst the micronutrient
anaemia, megaloblastic anaemia is the most common
non-malignant disorder in our patients. In other
similar studies its frequency ranges from as low as
24% to as high as 68% (4, 5). In almost all these studies
pancytopenia was the main presentation and so was
the case in our study. Rarely megaloblastic anaemia
may present with thrombocytopenia only (6).
The cause of megaloblastic anaemia is folate
deﬁciency and vitamin B12 deﬁciency. The usual
presenting feature of megaloblastic anaemia
in our patients was macrocytic anaemia and
symptoms of pancytopenia (thrombocytopenia and
neutropenia).
Amongst other micronutrient anaemia, iron
deﬁciency accounted for 6.5% only. This percentage is
much lower than expected as an estimated 60 to 80% of
the world’s population has this nutritional deﬁciency
(7). The possible explanation is that majority of the
patients are diagnosed on peripheral blood smear
examination and on serum ferritin levels and are
treated as outpatients.
Aplastic anaemia was also reported in some
of our patients (1.3%). Epidemiologically, aplastic
anaemia has a pattern of geographic variation
opposite to that of leukaemia, with higher frequency
in the developing world than in the industrialised
West. Although not a common disease worldwide,
aplastic anaemia has a social impact disproportionate
to its incidence. Large prospective studies indicate
an annual incidence of two new cases per million
populations in Europe and Israel (8). The rate is
much higher in the developing world, where aplastic
anaemia may rival acute myelogenous leukaemia in
frequency of diagnosis in haematology clinics. This
has been shown from the studies in Thailand and
China, where the incidence has been determined
to be about threefold that in the West (9). European
studies have conﬁrmed and quantiﬁed medical
drugs as risks for the development of marrow failure.
Surprisingly, drug use accounts for only a small
fraction of the disease in Thailand, where it is almost
always idiopathic. Prognosis is directly related to the
reduction in peripheral blood counts, particularly
the neutrophil number: < 200 granulocytes/µL
deﬁnes the category of severe disease (10). Recurrent
bacterial sepsis or fungal invasion of critical organs
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secondary to refractory neutropenia is the usual cause
of death. Its exact aetiology is still not known but
an autoimmune mechanism has been inferred from
positive responses to non transplant therapies and
laboratory data (11).
Idiopathic thrombocytopaenia purpura was the
third most common non malignant haematological
disorder found on bone marrow examination in our
patients. Idiopathic thrombocytopaenic purpura
(ITP) is a condition of having a low platelet count
(thrombocytopenia) of no known cause (idiopathic).
As most causes appear to be related to antibodies
against platelets, it is also known as immune
thrombocytopenic purpura. The incidence of ITP is
50-100 new cases per million per year, with children
accounting for half of that amount. More than 70% of
the cases in children end up in remission within six
months whether treated or not. Moreover, a third of
the remaining chronic cases remit during the followup observation, and another third ended up with only
mild thrombocytopenia (>50,000 platelets per µL)
(12). The paediatric age group in our study did not
have a case of ITP and this can be attributed to the
fact that bone marrow examination is hardly ever
needed to make a diagnosis of paediatric ITP. ITP is
usually chronic in adults (13) and the probability of
durable remission is 20-40% (14). The male: female
ratio in the adult group is 1:1.2-1.7 (for children it is
1:1) and the median age of adults at the diagnosis
is 56-60 (15). This was hardly the case in our study
where the condition was rampant in the young adults
(19-40 years).
In this study, 29 (8.1%) cases of leukaemia
were noted, with acute myeloid leukaemia being
the commonest, which was followed by low grade
lymphoproliferative disorders mainly chronic
lymphocytic leukaemia. Acute myeloid leukaemia
(AML), also known as acute myelogenous leukaemia,
is a cancer of the myeloid line of leucocytes,
characterised by the rapid proliferation of abnormal
cells which accumulate in the bone marrow and
interfere with the production of normal blood cells.
AML is the most common acute leukaemia affecting
adults, and its incidence increases with age. Although
AML is a relatively rare disease, accounting for
approximately 1.2% of cancer deaths in the United
States (16) its incidence is expected to increase as
the population ages.
Normal and reactive bone marrows were
found in one third of our patients and therefore a
conﬁrmatory diagnosis was made in two thirds of
the patients. This goes to show that bone marrow
examination is a useful test and diagnosis can be
made in a majority of patients, where the procedure
is indicated.
In about 2.8%, the bone marrow aspirate material
was inadequate for evaluation and this could point
towards a ﬁbrotic lesion in the bone marrow or
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inadequate technique. This procedure is fairly easy
to perform and yields information in almost all bone
marrow examination, as shown by the low incidences
of getting inadequate material for evaluation.
In conclusion, amongst the non-malignant
haematological disorders, nutritional anaemia as a
group was the most common disorder found on bone
marrow examination in this study, megaloblastic
anaemia being the most common followed by
iron deﬁciency anaemia. HIV dyspoiesis was the
second commonest bone marrow ﬁnding in this
study. Acute myeloid leukaemia was the most
common haematological malignancy followed by
lymphoproliferative disorders. The most common
indication for bone marrow examination was anaemia
followed by bone marrow cultures for diagnostic
work up of fever of unknown origin.
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